title: Expanded RAS: refining the patient population.
authors.affiliation: Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA chloe.atreya@ucsf.edu.
authors.forename: Chloe E
authors.initials: CE
authors.lastname: Atreya
authors.affiliation: Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA.
authors.forename: Ryan B
authors.initials: RB
authors.lastname: Corcoran
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Scott
authors.initials: S
authors.lastname: Kopetz
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000068258:Bevacizumab; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D000068818:Cetuximab; D003062:Codon; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005472:Fluorouracil / Q000008:administration & dosage; D020558:GTP Phosphohydrolases / Q000032:analysis / Q000235:genetics; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008565:Membrane Proteins / Q000032:analysis / Q000235:genetics; D058990:Molecular Targeted Therapy / Q000379:methods*; D009154:Mutation; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077544:Panitumumab; D016133:Polymerase Chain Reaction / Q000379:methods; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000235:genetics; D048493:Proto-Oncogene Proteins B-raf / Q000032:analysis / Q000235:genetics; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins / Q000032:analysis* / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003062:Codon; C117307:KRAS protein, human; D008565:Membrane Proteins; D009944:Organoplatinum Compounds; D011518:Proto-Oncogene Proteins; D000068258:Bevacizumab; D000077544:Panitumumab; C512478:EGFR protein, human; D066246:ErbB Receptors; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D020558:GTP Phosphohydrolases; C579846:NRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins; D000068818:Cetuximab; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin